Your browser doesn't support javascript.
loading
X-box binding protein 1-mediated COL4A1s secretion regulates communication between vascular smooth muscle and stem/progenitor cells.
Angbohang, Angshumonik; Huang, Lei; Li, Yi; Zhao, Yue; Gong, Yijie; Fu, Yi; Mao, Chenfeng; Morales, Jose; Luo, Peiyi; Ehteramyan, Mazdak; Gao, Yingtang; Margariti, Andriana; Gu, Wenduo; Zhang, Min; Smith, Alberto; Shah, Ajay M; Li, Tong; Kong, Wei; Zeng, Lingfang.
Afiliação
  • Angbohang A; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Huang L; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK; Department of Heart Center, Tianjin Third Central Hospital, Tianjin, P.R. China; Tianjin Key Laboratory of Ext
  • Li Y; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Zhao Y; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK; Department of Heart Center, Tianjin Third Central Hospital, Tianjin, P.R. China; Tianjin Key Laboratory of Ext
  • Gong Y; The Third Central Clinical College of Tianjin Medical University, Tianjin, P.R. China.
  • Fu Y; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P.R. China.
  • Mao C; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P.R. China.
  • Morales J; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Luo P; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Ehteramyan M; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Gao Y; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, P.R. China; Tianjin Institute of Hepatobiliary Disease, the Third Affiliated Hospital of Nankai University, Tianjin, P.R. China.
  • Margariti A; Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Gu W; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Zhang M; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Smith A; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Shah AM; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Li T; Department of Heart Center, Tianjin Third Central Hospital, Tianjin, P.R. China; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, P.R. China. Electronic address: litong3zx@sina.com.
  • Kong W; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P.R. China. Electronic address: kongw@bjmu.edu.cn.
  • Zeng L; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Science and Medicine, King's College London, London, UK. Electronic address: lingfang.zeng@kcl.ac.uk.
J Biol Chem ; 296: 100541, 2021.
Article em En | MEDLINE | ID: mdl-33722606
ABSTRACT
Vascular smooth muscle cells (VSMCs) contribute to the deposition of extracellular matrix proteins (ECMs), including Type IV collagen, in the vessel wall. ECMs coordinate communication among different cell types, but mechanisms underlying this communication remain unclear. Our previous studies have demonstrated that X-box binding protein 1 (XBP1) is activated and contributes to VSMC phenotypic transition in response to vascular injury. In this study, we investigated the participation of XBP1 in the communication between VSMCs and vascular progenitor cells (VPCs). Immunofluorescence and immunohistology staining revealed that Xbp1 gene was essential for type IV collagen alpha 1 (COL4A1) expression during mouse embryonic development and vessel wall ECM deposition and stem cell antigen 1-positive (Sca1+)-VPC recruitment in response to vascular injury. The Western blot analysis elucidated an Xbp1 gene dose-dependent effect on COL4A1 expression and that the spliced XBP1 protein (XBP1s) increased protease-mediated COL4A1 degradation as revealed by Zymography. RT-PCR analysis revealed that XBP1s in VSMCs not only upregulated COL4A1/2 transcription but also induced the occurrence of a novel transcript variant, soluble type IV collagen alpha 1 (COL4A1s), in which the front part of exon 4 is joined with the rear part of exon 42. Chromatin-immunoprecipitation, DNA/protein pulldown and in vitro transcription demonstrated that XBP1s binds to exon 4 and exon 42, directing the transcription from exon 4 to exon 42. This leads to transcription complex bypassing the internal sequences, producing a shortened COL4A1s protein that increased Sca1+-VPC migration. Taken together, these results suggest that activated VSMCs may recruit Sca1+-VPCs via XBP1s-mediated COL4A1s secretion, leading to vascular injury repair or neointima formation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco / Comunicação Celular / Movimento Celular / Colágeno Tipo IV / Proteína 1 de Ligação a X-Box / Músculo Liso Vascular Limite: Animals / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco / Comunicação Celular / Movimento Celular / Colágeno Tipo IV / Proteína 1 de Ligação a X-Box / Músculo Liso Vascular Limite: Animals / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido